Piperacillin & Tazobactam 4.5g for Injection
Piperacillin/tazobactam is indicated for the treatment of the following infections in adults and children over 2 years of age: Adults and adolescents - Severe pneumonia including hospital-acquired and ventilator-associated pneumonia - Complicated urinary tract infections (including pyelonephritis) - Complicated intra-abdominal infections - Complicated skin and soft tissue infections (including diabetic foot infections). Treatment of patients with bacteremia associated with or suspected to be associated with any of the aforementioned infections. Piperacillin/tazobactam can be used in the management of neutropenic patients with fever suspected to be caused by a bacterial infection. Children aged 2 to 12 years - Complicated intra-abdominal infections. Piperacillin/tazobactam can be used in the management of neutropenic children with fever suspected to be caused by a bacterial infection. Official recommendations on the appropriate use of antibacterial agents should be taken into account.
Pharmaceutical form
Injectable
Concentration
4.5g
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.
